Compare MRK & ETN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRK | ETN |
|---|---|---|
| Founded | 2000 | 1916 |
| Country | United States | Ireland |
| Employees | N/A | 101000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 160.3B |
| IPO Year | 1994 | 2012 |
| Metric | MRK | ETN |
|---|---|---|
| Price | $115.30 | $410.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 22 |
| Target Price | $125.59 | ★ $401.95 |
| AVG Volume (30 Days) | ★ 8.2M | 2.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.06% | 1.07% |
| EPS Growth | 8.01 | ★ 10.00 |
| EPS | N/A | ★ 2.22 |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.61 | $12.72 |
| Revenue Next Year | $5.41 | $9.54 |
| P/E Ratio | ★ N/A | $176.30 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $76.66 | $311.92 |
| 52 Week High | $125.14 | $435.43 |
| Indicator | MRK | ETN |
|---|---|---|
| Relative Strength Index (RSI) | 46.40 | 54.00 |
| Support Level | $112.96 | $353.32 |
| Resistance Level | $123.93 | $431.01 |
| Average True Range (ATR) | 2.95 | 14.31 |
| MACD | -0.12 | -0.56 |
| Stochastic Oscillator | 13.90 | 68.68 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Founded in 1911 by Joseph Eaton, the eponymous company began by selling truck axles in New Jersey. Eaton has since become an industrial powerhouse largely through acquisitions in various end markets. Eaton's portfolio can broadly be divided into two parts: its electrical and industrial businesses. Its electrical portfolio (representing around 70% of company revenue) sells components within data centers, utilities, and commercial and residential buildings, while its industrial business (30% of revenue) sells components within commercial and passenger vehicles and aircraft. Eaton receives favorable tax treatment as a domiciliary of Ireland, but it generates over half of its revenue within the US.